6-((3R)-3-(2,4-DIFLUOROPHENYL)-2-ISOXAZOLIDINYL)-N-(5-ETHYL-2-METHOXY-4-(4-(4-METHYL-1-PIPERAZINYL)-1-PIPERIDINYL)PHENYL)-4-PYRIMIDINAMINE
UNII X9NB39JJK2

Substance Identification & Data

This profile provides standardized clinical and technical data for 6-((3r)-3-(2,4-difluorophenyl)-2-isoxazolidinyl)-n-(5-ethyl-2-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)-4-pyrimidinamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) X9NB39JJK2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2869091-52-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

X9NB39JJK2

CAS Registry Number

2869091-52-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

6-((3R)-3-(2,4-DIFLUOROPHENYL)-2-ISOXAZOLIDINYL)-N-(5-ETHYL-2-METHOXY-4-(4-(4-METHYL-1-PIPERAZINYL)-1-PIPERIDINYL)PHENYL)-4-PYRIMIDINAMINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C32H41F2N7O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XRESFFNGPJGKMK-MUUNZHRXSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

166135215

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

Fc1c([C@@H]2N(OCC2)c3cc(Nc4c(OC)cc(c(CC)c4)N5CCC(CC5)N6CCN(C)CC6)ncn3)ccc(F)c1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 6-((3r)-3-(2,4-difluorophenyl)-2-isoxazolidinyl)-n-(5-ethyl-2-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)-4-pyrimidinamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.